Regulating manufacturer-affiliated communication in the information age

Clin Pharmacol Ther. 1999 Jun;65(6):593-7. doi: 10.1016/S0009-9236(99)90080-2.

Authors

K A Schulman¹, D R Abernethy, S S Rathore, R L Woosley

Affiliation

¹ Department of Medicine, Georgetown University Medical Center, Washington, DC 20007, USA. schulmak@gunet.georgetown.edu

PMID: 10391664
DOI: 10.1016/S0009-9236(99)90080-2

No abstract available

MeSH terms

Conflict of Interest*
Drug Industry / economics
Drug Industry / legislation & jurisprudence*
Drug Industry / standards
Drug Information Services / legislation & jurisprudence*
Drug Information Services / standards
Guidelines as Topic
Humans
Insurance, Pharmaceutical Services / legislation & jurisprudence*
Marketing of Health Services / economics
Marketing of Health Services / legislation & jurisprudence*
Marketing of Health Services / standards
Truth Disclosure
United States
United States Food and Drug Administration